Piia Tarkkinen1, Tom Palenius, Timo Lövgren. 1. Department of Biotechnology, University of Turku, Tykistökatu 6A, 6th Floor, FIN-20520 Turku, Finland. piia.tarkkinen@utu.fi
Abstract
BACKGROUND: Recently, measurement of very low concentrations of C-reactive protein (CRP) has gained popularity as a potential new means for predicting the risk of future cardiac complications. In this study, we demonstrate the feasibility of a kinetic, one-step microparticle assay for quantitative determination of extremely low and high CRP concentrations in the limited timeframe typical for point-of-care testing. METHODS: A noncompetitive, kinetic CRP immunoassay was developed that uses individual, porous microparticles as the solid phase. The microparticles were covalently coated with a monoclonal capture antibody, and the monoclonal detection antibody was labeled with europium. The one-step binding reaction was stopped by washing after 2 min of incubation, and the fluorescence signal of individual particles was measured. RESULTS: The analytical detection limit (mean of zero calibrator + 3 SD) was 0.00016 mg/L CRP. Clinical samples were diluted 400-fold before assay to cover the CRP concentration range of 0.064-1200 mg/L. The assay correlated well with the Dade Behring N High Sensitivity CRP assay (for 0-10 mg/L, r = 0.969, S(y/x) = 0.68, n = 54; for 0-350 mg/L, r = 0.969, S(y/x) = 11.7, n = 100). The within- and between-run CVs based on calculated concentrations were, respectively, 9-16% and 14% at 0.11 mg/L, 4.5-12% and 8.2% at 4.2 mg/L, and 3.5-6.3% and 4.4% at 105 mg/L, with a CV <15% at 0.2 mg/L and above. CONCLUSIONS: Use of the kinetic microparticle approach combined with time-resolved fluorometry allows ultrasensitive quantification of CRP in whole blood in 2 min with a linear assay range spanning more than four orders of magnitude.
BACKGROUND: Recently, measurement of very low concentrations of C-reactive protein (CRP) has gained popularity as a potential new means for predicting the risk of future cardiac complications. In this study, we demonstrate the feasibility of a kinetic, one-step microparticle assay for quantitative determination of extremely low and high CRP concentrations in the limited timeframe typical for point-of-care testing. METHODS: A noncompetitive, kinetic CRP immunoassay was developed that uses individual, porous microparticles as the solid phase. The microparticles were covalently coated with a monoclonal capture antibody, and the monoclonal detection antibody was labeled with europium. The one-step binding reaction was stopped by washing after 2 min of incubation, and the fluorescence signal of individual particles was measured. RESULTS: The analytical detection limit (mean of zero calibrator + 3 SD) was 0.00016 mg/L CRP. Clinical samples were diluted 400-fold before assay to cover the CRP concentration range of 0.064-1200 mg/L. The assay correlated well with the Dade Behring N High Sensitivity CRP assay (for 0-10 mg/L, r = 0.969, S(y/x) = 0.68, n = 54; for 0-350 mg/L, r = 0.969, S(y/x) = 11.7, n = 100). The within- and between-run CVs based on calculated concentrations were, respectively, 9-16% and 14% at 0.11 mg/L, 4.5-12% and 8.2% at 4.2 mg/L, and 3.5-6.3% and 4.4% at 105 mg/L, with a CV <15% at 0.2 mg/L and above. CONCLUSIONS: Use of the kinetic microparticle approach combined with time-resolved fluorometry allows ultrasensitive quantification of CRP in whole blood in 2 min with a linear assay range spanning more than four orders of magnitude.
Authors: Evgenia G Matveeva; Ignacy Gryczynski; Joanna Malicka; Zygmunt Gryczynski; Ewa Goldys; Joseph Howe; Klaus W Berndt; Joseph R Lakowicz Journal: J Fluoresc Date: 2005-11 Impact factor: 2.217
Authors: Evgenia G Matveeva; Zygmunt Gryczynski; Joanna Malicka; Joanna Lukomska; Slawomir Makowiec; Klaus W Berndt; Joseph R Lakowicz; Ignacy Gryczynski Journal: Anal Biochem Date: 2005-09-15 Impact factor: 3.365
Authors: Maria Fuentes-Rubio; Francisco Fuentes; Julio Otal; Alberto Quiles; María Luisa Hevia Journal: Can J Vet Res Date: 2016-07 Impact factor: 1.310
Authors: Asta Tvarijonaviciute; Jose J Ceron; Shelley L Holden; Daniel J Cuthbertson; Vincent Biourge; Penelope J Morris; Alexander J German Journal: BMC Vet Res Date: 2012-08-28 Impact factor: 2.741
Authors: Thomas Brevig; Ulrich Krühne; Rachel A Kahn; Thomas Ahl; Michael Beyer; Lars H Pedersen Journal: BMC Biotechnol Date: 2003-07-23 Impact factor: 2.563